Trial Profile
A study of doxorubicin transferrin conjugate [TRF-DOX] in patients with acute leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin conjugate (Primary)
- Indications Leukaemia
- Focus Therapeutic Use
- 16 Apr 2015 New trial record